ES2616035T3 - Preparación para su uso en la profilaxis y el tratamiento de osteoporosis atípica - Google Patents

Preparación para su uso en la profilaxis y el tratamiento de osteoporosis atípica Download PDF

Info

Publication number
ES2616035T3
ES2616035T3 ES12874454.7T ES12874454T ES2616035T3 ES 2616035 T3 ES2616035 T3 ES 2616035T3 ES 12874454 T ES12874454 T ES 12874454T ES 2616035 T3 ES2616035 T3 ES 2616035T3
Authority
ES
Spain
Prior art keywords
preparation
prophylaxis
treatment
osteoporosis
atypical osteoporosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12874454.7T
Other languages
English (en)
Inventor
Villorij Ivanovich STRUKOV
Olga JHONES
Evgenij Nikolaevich KRUTIAKOV
Konstantin Gennad'evich ELISTRATOV
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parafarm OOO
Original Assignee
Parafarm OOO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parafarm OOO filed Critical Parafarm OOO
Application granted granted Critical
Publication of ES2616035T3 publication Critical patent/ES2616035T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Insects & Arthropods (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)

Abstract

Una preparación para prevenir o tratar osteoporosis atípica con mineralización de tejido óseo normal o elevada y la presencia de cavidades en secciones de hueso trabecular que comprende cría de zánganos en una cantidad de 10 mg a 1000 mg y vitamina D o vitaminas del grupo D y/o sus metabolitos activos en una cantidad de 50 UI a 100.000 UI como dosis diarias.

Description

imagen1
imagen2
imagen3
imagen4

Claims (1)

  1. imagen1
ES12874454.7T 2012-04-19 2012-08-21 Preparación para su uso en la profilaxis y el tratamiento de osteoporosis atípica Active ES2616035T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2012115654/15A RU2497533C1 (ru) 2012-04-19 2012-04-19 Способ и препарат для профилактики и лечения атипичного остеопороза с нормальной или повышенной минерализацией костной ткани с наличием полостных образований в трабекулярных отделах костей (и ему близких состояниях при избыточной массе и метаболическом синдроме)
RU2012115654 2012-04-19
PCT/RU2012/000687 WO2013157982A1 (ru) 2012-04-19 2012-08-21 Препарат и способ профилактики и лечения атипичного остеопороза

Publications (1)

Publication Number Publication Date
ES2616035T3 true ES2616035T3 (es) 2017-06-09

Family

ID=49383800

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12874454.7T Active ES2616035T3 (es) 2012-04-19 2012-08-21 Preparación para su uso en la profilaxis y el tratamiento de osteoporosis atípica

Country Status (17)

Country Link
US (1) US9827273B2 (es)
EP (1) EP2845598B1 (es)
JP (1) JP6286417B2 (es)
CN (1) CN104736161B (es)
AU (1) AU2012377476B2 (es)
BR (1) BR112014025990B1 (es)
CA (1) CA2870823C (es)
DK (1) DK2845598T3 (es)
EA (1) EA026533B1 (es)
ES (1) ES2616035T3 (es)
IL (1) IL235169B (es)
IN (1) IN2014DN09780A (es)
LT (1) LT2845598T (es)
PL (1) PL2845598T3 (es)
RU (1) RU2497533C1 (es)
UA (1) UA111536C2 (es)
WO (1) WO2013157982A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180249751A1 (en) * 2009-11-30 2018-09-06 Parapharm Llc Preparation for Treating Androgen Deficiency in Women
US20190381072A1 (en) * 2012-04-19 2019-12-19 Parapharm Llc Preparation for the Prophylaxis and Treatment of Atypical Osteoporosis
RU2498811C1 (ru) * 2012-04-19 2013-11-20 Общество С Ограниченной Ответственностью "Парафарм" Способ профилактики и лечения остеопороза и переломов костей и препарат для профилактики и лечения остеопороза и переломов костей
RU2564111C9 (ru) * 2013-07-03 2016-03-20 Общество С Ограниченной Ответственностью "Парафарм" Применение адсорбированного гомогената трутневого расплода и витаминов группы d и/или их активных метаболитов для профилактики и лечения острых респираторных заболеваний и гриппа
RU2577225C1 (ru) * 2015-03-27 2016-03-10 Общество С Ограниченной Ответственностью "Парафарм" Препарат и способ для лечения дефицита андрогенов у женщин, содержащий энтомологические протеины
EP4268688A4 (en) * 2021-04-13 2024-09-04 Samsung Electronics Co Ltd COOKING APPARATUS AND CONTROL METHODS THEREFOR

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1101684C (zh) * 1997-07-24 2003-02-19 薛大权 蜂蛹钙制剂
CA2526845A1 (en) * 2003-06-06 2005-03-31 Wyeth Methods and materials for identifying agents which modulate bone remodeling and agents identified thereby
JP5509504B2 (ja) * 2008-02-13 2014-06-04 ディーエスエム アイピー アセッツ ビー．ブイ． 骨塩密度を改善し、骨粗鬆症を治療するための２５−ヒドロキシ−ビタミンｄ３とビタミンｄ３の併用
RU2412616C1 (ru) * 2009-11-30 2011-02-27 Общество С Ограниченной Ответственностью "Парафарм" Биологически активная добавка к пище для профилактики заболеваний остеопорозом

Also Published As

Publication number Publication date
AU2012377476A1 (en) 2014-12-11
IN2014DN09780A (es) 2015-07-31
IL235169B (en) 2019-10-31
EA026533B1 (ru) 2017-04-28
AU2012377476B2 (en) 2017-10-05
BR112014025990B1 (pt) 2021-02-17
US9827273B2 (en) 2017-11-28
AU2012377476A8 (en) 2014-12-18
CN104736161B (zh) 2021-07-06
BR112014025990A2 (pt) 2017-06-27
EP2845598A4 (en) 2015-10-28
JP2015516974A (ja) 2015-06-18
WO2013157982A1 (ru) 2013-10-24
EA201401155A1 (ru) 2015-05-29
DK2845598T3 (en) 2017-04-10
US20150224150A1 (en) 2015-08-13
UA111536C2 (uk) 2016-05-10
IL235169A0 (en) 2014-12-31
CA2870823C (en) 2017-10-03
RU2497533C1 (ru) 2013-11-10
CA2870823A1 (en) 2013-10-24
EP2845598A1 (en) 2015-03-11
PL2845598T3 (pl) 2017-07-31
LT2845598T (lt) 2017-02-27
CN104736161A (zh) 2015-06-24
JP6286417B2 (ja) 2018-02-28
EP2845598B1 (en) 2017-01-04

Similar Documents

Publication Publication Date Title
ES2616035T3 (es) Preparación para su uso en la profilaxis y el tratamiento de osteoporosis atípica
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
CL2018000706A1 (es) Derivados de pirazolopirimidina como inhibidores btk para el tratamiento del cancer.
CL2017000156A1 (es) Procedimientos para el tratamiento de paramixovirus.
CL2016002812A1 (es) Uso de ácido 3-2,3,5,6-tetrafluoro-3-trifluorometoxi-bifenil-4-ilcarbamoil-tiofeno-2-carboxílico para preparar un medicamento útil para tratar una enfermedad ocular que es uveítis, ojo seco o causada por un adenovirus composición formulación.
CO7101245A2 (es) Compuestos de benzaldehído sustituidos y métodos para su uso en incrementar la oxigenación del tejido
PE20211069A1 (es) Composicion que comprende 5'-metilselenoadenosina, selenoadenosil-l-homocisteina y gama glutamil-metilselenocisteina
UY35040A (es) Pirrolopirimidinilamino-benzotiazolonas sustituidas
NI201500118A (es) Imidazopiridazinas sustituidas
CO2017005968A2 (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2
DOP2016000007A (es) Pirazolpiridinas sustituidas
DOP2016000118A (es) Tienopirimidinas como inhibidores mknk1 y mknk2
ES2508165T3 (es) Lactoferrina y sustancia blanca
CR20150653A (es) Compuestos nuevos para el tratamiento del cáncer
CL2015001446A1 (es) Procedimiento de preparación de albumina humana con nivel de oxigeno disuelto reducido.
UY34931A (es) ?formulación compuesta para administración oral que comprende metformina y rosuvastatina?.
ES2619428T3 (es) Composición en polvo para desinfección de las ubres de los animales lecheros
AR098832A1 (es) Uso de laquinimod para retrasar la progresión de la enfermedad de huntington
CO6311076A2 (es) Una composición que comprende 2-n-butil-3-[4-(3-di-n-butilaminopropoxi)benzoil]-5-metilsulfonamido-benzofurano y sus sales aceptables farmacéuticamente
CL2018001104A1 (es) Composición para el cuidado de la piel y procedimiento asociado.
CL2016000397A1 (es) Tratamiento contra el cáncer
ES2536842T3 (es) Composición farmacéutica para el tratamiento del cáncer
ES2507517T3 (es) Agente profiláctico o terapéutico para trastorno de déficit de atención con hiperactividad
AR106415A1 (es) Composición farmacéutica para el tratamiento del dolor
ES2656666T3 (es) Alimento para fines médicos especiales o formulación de suplemento alimenticio para tratar trastornos auditivos